|
Volumn 42, Issue 5, 2016, Pages 946-948
|
Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case–control study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
ANTIINFECTIVE AGENT;
ADULT;
AGED;
ANTIBIOTIC THERAPY;
AREA UNDER THE CURVE;
ARTIFICIAL VENTILATION;
CLINICAL ARTICLE;
CONTINUOUS RENAL REPLACEMENT THERAPY;
CRITICALLY ILL PATIENT;
DRUG BLOOD LEVEL;
EXTRACORPOREAL OXYGENATION;
HUMAN;
LETTER;
LOADING DRUG DOSE;
MAXIMUM PLASMA CONCENTRATION;
OBSERVATIONAL STUDY;
CASE CONTROL STUDY;
CRITICAL ILLNESS;
FEMALE;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
INTENSIVE CARE UNIT;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
AMIKACIN;
ANTI-BACTERIAL AGENTS;
CASE-CONTROL STUDIES;
CRITICAL ILLNESS;
EXTRACORPOREAL MEMBRANE OXYGENATION;
FEMALE;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
HUMANS;
INTENSIVE CARE UNITS;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 84961665634
PISSN: 03424642
EISSN: 14321238
Source Type: Journal
DOI: 10.1007/s00134-016-4267-x Document Type: Letter |
Times cited : (26)
|
References (5)
|